The NLRP3–ASC inflammasome (iv), scrutinized as therapeutic target for many disorders and previously identified as Aβ-related therapeutic target, is herewith identified as a target for Tauopathies including AD. The gene discussed is NLRP3; the disease is Alzheimer disease.